Sage Journals: Discover world-class research

Abstract

Effective and efficient assessment of the potential health effects from environmental chemicals requires well-validated tests to identify the toxicity of the chemical and then extensive scientific and analytical work to characterize the potential risk for humans in light of the relative potency of the chemical in test systems, the nature and routes of exposures for humans, and the differences in susceptibility across species and among human population subgroups. Such risk assessment is being applied increasingly for potential carcinogens and is beginning to be applied to mutagenic and teratogenic chemicals. One of the fertile areas for research is the study of mechanisms that may permit us to predict carcinogenic, mutagenic, or teratogenic activity of compounds from tests of each of these classes of end-points.

References

1. Office of Technology Assessment (U.S. Congress) (1981). Assessment of Technologies for Determining Cancer Risks from the Environment. June, 1981.

2. Calkins, D.R. , Dixon, R.L. , Gerber, C.R. , Zarin, D. , and Omenn, G.S. (1980). Identification, characterization, and control of potential human carcinogens: a framework for Federal decision-making. J. Natl. Cancer Inst. 64, 169–175.

3. Ames, B.N. (1981). Carcinogenic potency. Abst, Proc. 3rd Intl. Conf. on Environmental Mutagens, Tokyo, September 21-24, 1981. p. 9.

4. Crump, K.S. , Hoel, D.G. , Langley, C.H. , and Peto, R. (1976). Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36, 2973–2979.

5. Griesemer, R.A. and Cueto, Jr., C. (1980). Toward a classification scheme for degrees of experimental evidence for the carcinogenicity of chemicals for animals, in: Molecular and Cellular Aspects of Carcinogen Screening Tests. R. Montesano , H. Bartsch , and L. Tomatis (eds.). International Agency for Research on Cancer, Lyon: France.

6. Omenn, G.S. (1979). Genetics and epidemiology: medical interventions and public policy. Soc. Biol. 26, 117–125.

7. Friedman, R.D. (1979). Sensitive Populations and Environmental Standards: A Legal Analysis. The Conservation Foundation: Washington DC.

8. Omenn, G.S. and Motulsky, A.G. (1978). Eco-genetics: genetic variation in susceptibility to environmental agents, in: Genetic Issues in Public Health and Medicine. B. H. Cohen , A. M. Lilienfeld , and P. C. Huang (eds.). Springfield, IL: C.C. Thomas. pp. 83–111.

9. Omenn, G.S. (1982). Predictive identification of hypersusceptible individuals. J. Occ. Med. 24, 369–374.

10.

10. Bloom, A.D. (ed.): (1981). Guidelines for Studies of Human Populations Exposed to Mutagenic and Reproductive Hazards. March of Dimes Birth Defects Foundation: New York, 1981.

11.

11. EPA. (1982). Assessment of Risks to Human Reproduction and to Development of the Human Conceptus from Exposure to Environmental Substances. Oak Ridge National Laboratory: ORNL/EIS-197, EPA-600/ 9-82-001, February, 1982.

12.

12. EPA. (1980). Mutagenicity risk assessments: proposed guidelines. Fed. Reg. 45, 74984–74988.

13.

13. EPA. (1976). Interim procedures and guidelines for health risk and economic impact assessments of suspected carcinogens. Fed. Reg. 41, 21402–21405.

14.

14. Schull, W.J. , Otake, M. and Neel, J.V. (1981). A reappraisal of the genetic effects of the atomic bombs: summary of a thirty-four year study. Science 213, 1220–1227.

15.

15. Vogel, F. and Motulsky, A.G. (1979). Human Genetics: Problems and Approaches. Springer-Verlag: Berlin and New York. Chapter 5.

16.

16. Faustman-Watts, E., Greenaway, J., Namkung, M., Fantel, A., and Juchau, M. (1982). Teratogenicity in vitro of 2-acetylaminofluorene in the rat: role of biotransformation. Teratology, in press.

17.

17. Schardein, J.L. (1976). Drugs as Teratogens. CRC Press: Cleveland. pp. 9–12.

18.

18. Shepard, T.H. (1980). Catalog of Teratogenic Agents 3rd ed. Johns Hopkins Press: Baltimore, MD.

Environmental Risk Assessment: Relation to Mutagenesis,Teratogenesis,and Reproductive Effects

Abstract

References